Long or Post COVID syndrome. Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms and that last for at least 2 months and cannot be explained by an alternative diagnosis.
Conditions
Interventions
Intervention 1: Intervention group: The drug fluvoxamine maleate 50 mg fc tablet made by Jalinous Pharmaceutical Company, every 12 hours for 10 days, after 4 weeks, patients are contacted and asked a
Sponsors
Artesh University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: Confirmed COVID infection by infectious disease specialist Age over 15 years
Exclusion criteria
Exclusion criteria: History of epilepsy History of mania History of depression Use of other antidepressants Pregnancy and lactationK Kidney dysfunction Liver dysfunction History of cardiac arrhythmia Any drug allergy to fluvoxamine, including skin allergies Severe side effects of fluvoxamine, including malignant neuroleptic syndrome Drug interactions with other drugs consumed by the patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of any of the neuropsycological symptoms of Long COVID in patients. Timepoint: 4 weeks after COVID symptoms onset. Method of measurement: history taking based on a questionnaire prepared by the researcher. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Ajam
Tehran University of Medical Sciences
Outcome results
None listed